Sai Life Sciences share price

High risk
  • 49%Low risk
  • 49%Moderate risk
  • 49%Balanced risk
  • 49%High risk
  • 49%Extreme risk
  • ₹765.85(5.03%)
    June 20, 2025 15:40:32 PM IST
    • NSE
    • BSE
  • Vol : 25.42M (NSE + BSE)
    Last 20 day avg : 1.78 M

Sai Life Sciences is trading 5.03% upper at Rs 765.85 as compared to its last closing price. Sai Life Sciences has been trading in the price range of 793.35 & 720.35. Sai Life Sciences has given 1.87% in this year & -0.62% in the last 5 days. There are 3 analysts who have initiated coverage on Sai Life Sciences. There are 0.00 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.Listed peers of Sai Life Sciences include Ventive Hospitality (0.14%), Afcons Infrastructure (5.45%), Sai Life Sciences (5.03%).The Mutual Fund holding in Sai Life Sciences was at 11.54% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Sai Life Sciences was at 12.36% in 31 Mar 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on Jun 22, 2025, 01:54 AM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    7.49
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    91.90
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
720.35
Highest
793.35
52 week range
Lowest
635.30
Highest
808.20
Sai Life Sciences News
Sai Life Sciences Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Sai Life Sciences Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 805.12
  • R2
  • 852.23
  • R3
  • 902.57
Pivot754.78
  • S1
  • 707.67
  • S2
  • 657.33
  • S3
  • 610.22
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Sai Life Sciences Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Ventive Hospitality
Bearish
701.450.1416,392.3199.673.4-53.62
Afcons Infrastructure
Neutral
447.605.4516,462.0433.223.07-12.42
Sai Life Sciences
Bullish
765.855.0315,949.3788.887.49-7.74
Blue Jet Healthcare
Neutral
875.002.1615,248.5449.1913.250.121.46
Acme Solar Holdings
Neutral
246.850.2215,015.8551.493.320.08229.73
Sai Life Sciences Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Sai Life Sciences is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPledged found - Promoter(s) have pledged 2.67% of shares.
    • InsightsPledging Flat - Promoter(s) pledging has not increased in last quarter.
    • InsightsPromoter(s) holding is moderate at 35.17%
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has increased by 0.64 percentage points from previous quarter
    • InsightsMutual Funds holding has increased by 1.35 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    DSP Healthcare Fund Regular Growth
    NA
    • Amount Invested (Cr.) 120.90
    • % of AUM 4.08
    Aditya Birla Sun Life Retirement Fund - The 40s Pln Regular Growth
    NA
    • Amount Invested (Cr.) 3.03
    • % of AUM 2.63
    Edelweiss Recently Listed IPO Fund Regular Plan Growth
    NA
    • Amount Invested (Cr.) 22.71
    • % of AUM 2.54
    Mirae Asset Healthcare Fund Regular Growth
    NA
    • Amount Invested (Cr.) 66.73
    • % of AUM 2.48
    Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth
    NA
    • Amount Invested (Cr.) 19.31
    • % of AUM 2.37
    Sai Life Sciences Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-13Audited Results
    2025-02-06Quarterly Results
    About the company Sai Life Sciences
    • Industry
    • ISININE570L01029
    • BSE Code544306
    • NSE CodeSAILIFE
    Sai Life Sciences Limited is an India-based contract research, development, and manufacturing organization (CRO/CDMO). The Company carries out contract research and manufacturing activities for customers engaged in pharmaceutical and biotechnology industries. It is engaged in offering a range of services tailor-made to the customer's requirements. It provides discovery and chemistry, manufacturing, and controls (CMC) services that span from drug discovery to process development and early-phase supplies, all the way to commercial launch and life cycle management. Its services include Integrated Drug Discovery, Synthetic & medicinal chemistry, Biology, drug metabolism and pharmacokinetics (DMPK), Genotoxicity, General Toxicology and Computational chemistry. Its CMC services include route scouting; process development; analytical development; process safety; stability studies; early and mid-phase supplies; late phase, commercial manufacturing; technology transfer, and technologies.
    • Management Info
    • Krishnam KanumuriChief Executive Officer, Managing Director (Promoter)
    • Sivaramakrishnan ChittorChief Financial Officer, Additional Director
    • Kanumuri RajuWhole-Time Director (Promoter)
    • Runa KaranCompany Secretary
    Sai Life Sciences Share Price FAQs

    Sai Life Sciences is trading at 765.85 as on Fri Jun 20 2025 10:10:32. This is 5.03% upper as compared to its previous closing price of 729.20.

    The market capitalization of Sai Life Sciences is 15949.37 Cr as on Fri Jun 20 2025 10:10:32.

    The average broker rating on Sai Life Sciences is Hold. The breakup of analyst rating is given below -

    • 0.00 analysts have given a strong buy rating
    • 1 analysts have given a buy rating
    • 1 analysts have given a hold rating
    • 1 analysts have given a sell rating
    • 0.00 analysts have given a strong sell rating

    The 52 wk high for Sai Life Sciences is 808.20 whereas the 52 wk low is 635.30

    Sai Life Sciences can be analyzed on the following key metrics -

    • TTM P/E: 89.76
    • Sector P/E: -
    • Dividend Yield: 0.00%
    • D/E ratio: 0.17

    Sai Life Sciences reported a net profit of 170.13 Cr in 2025.

    The Mutual Fund Shareholding was 11.54% at the end of 31 Mar 2025.

    Quick Links
    EQUITY QUICK LINKS
    Sai Life Sciences QUICK LINKS
    FROM MARKETS
    RELATED LINKS
    Quarterly Results
    Business News/Market/Market Stats/   Sai Life Sciences share price

    Wait for it…

    Log in to our website to save your bookmarks. It'll just take a moment.